Board Meeting27 Jul 2026, 03:22 pm
Senores Pharmaceuticals Board Approves Unaudited Financial Results
AI Summary
Senores Pharmaceuticals Limited announced the outcome of its Board Meeting held on July 27, 2026. The board approved the unaudited consolidated and standalone financial results for the quarter ended June 30, 2026, along with the Limited Review Report from statutory auditors Pankaj R. Shah and Associates. Additionally, the board approved the appointment of Ms. Anjali Shah as Assistant Vice President-Finance and designated her as Senior Management Personnel (SMP) effective July 27, 2026. The company also confirmed that the auditors have issued their Limited Review Reports on the financial results.
Key Highlights
- Board approved unaudited financial results for Q1 FY27.
- Consolidated and standalone results were reviewed.
- Appointment of Ms. Anjali Shah as Senior Management Personnel approved.
- Limited Review Reports from auditors were received and approved.
Price Impact
More from SENORES